- Home
- DSM vs HRTX Comparison
DSM vs HRTX Comparison
Compare DSM & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSM
- HRTX
- Stock Information
- Founded
- DSM 1989
- HRTX 1983
- Country
- DSM United States
- HRTX United States
- Employees
- DSM N/A
- HRTX N/A
- Industry
- DSM Investment Managers
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- DSM Finance
- HRTX Health Care
- Exchange
- DSM Nasdaq
- HRTX Nasdaq
- Market Cap
- DSM 289.7M
- HRTX 270.7M
- IPO Year
- DSM N/A
- HRTX 1987
- Fundamental
- Price
- DSM $5.88
- HRTX $2.38
- Analyst Decision
- DSM
- HRTX Strong Buy
- Analyst Count
- DSM 0
- HRTX 3
- Target Price
- DSM N/A
- HRTX $5.67
- AVG Volume (30 Days)
- DSM 161.7K
- HRTX 2.7M
- Earning Date
- DSM 01-01-0001
- HRTX 05-06-2025
- Dividend Yield
- DSM 3.97%
- HRTX N/A
- EPS Growth
- DSM N/A
- HRTX N/A
- EPS
- DSM N/A
- HRTX N/A
- Revenue
- DSM N/A
- HRTX $144,285,000.00
- Revenue This Year
- DSM N/A
- HRTX $11.81
- Revenue Next Year
- DSM N/A
- HRTX $15.79
- P/E Ratio
- DSM N/A
- HRTX N/A
- Revenue Growth
- DSM N/A
- HRTX 13.57
- 52 Week Low
- DSM $4.69
- HRTX $1.04
- 52 Week High
- DSM $6.05
- HRTX $3.93
- Technical
- Relative Strength Index (RSI)
- DSM 31.77
- HRTX 58.92
- Support Level
- DSM $6.01
- HRTX $2.29
- Resistance Level
- DSM $6.10
- HRTX $2.56
- Average True Range (ATR)
- DSM 0.05
- HRTX 0.20
- MACD
- DSM -0.03
- HRTX -0.01
- Stochastic Oscillator
- DSM 7.14
- HRTX 46.43
About DSM BNY Mellon Strategic Municipal Bond Fund Inc.
BNY Mellon Strategic Municipal Bond Fund, Inc. is a diversified closed-end management investment company. Its investment objective is to seek to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.